SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Noncommunicable diseases, access to essential medicines and universal health coverage
15 references·0 citing·49 second hop
Noncommunicable diseases, access to essential medicines and universal health coverage (2019)Noncommunicable diseases, access to essen…Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals (2018)Investing in non-communicable…Health systems development in Thailand: a solid platform for successful implementation of universal health coverage (2018)Health systems development in…Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)Global, regional, and nationa…Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment (2018)Availability and Affordabilit…Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study (2018)Availability and affordabilit…Tracking Universal Health Coverage: 2017 Global Monitoring Report (2017)Tracking Universal Health Cov…Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)Global, regional, and nationa…Essential medicines for universal health coverage (2016)Essential medicines for unive…The role of law and governance reform in the global response to non-communicable diseases (2014)The role of law and governanc…Chronic non-communicable diseases and the challenge of universal health coverage: insights from community-based cardiovascular disease research in urban poor communities in Accra, Ghana (2014)Chronic non-communicable dise…Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration (2013)Promotion of access to essent…Advancing universal coverage of healthcare in China: translating political will into policy and practice (2013)Advancing universal coverage …Action on social determinants of health is essential to tackle noncommunicable diseases (2011)Action on social determinants…Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World (2010)Quantifying the Impoverishing…Health systems financing and the path to universal coverage (2010)Health systems financing and …Overcoming health-systems constraints to achieve the Millennium Development Goals (2004)Protecting Households From Catastrophic Health Spending (2007)Performance-based payment: some reflections on the discourse, evidence and unanswered questions (2009)Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 (2018)Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries (2018)Identifying Key Challenges Facing Healthcare Systems In Africa And Potential Solutions (2019)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Inequalities in non-communicable diseases and effective responses (2013)Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries (2013)World Health Report (2013)Gender equality in science, medicine, and global health: where are we at and why does it matter? (2019)Human Development Report (2001)Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation (2007)A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries (2011)Universal Declaration of Human Rights (2011)The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries (2013)Revisiting the issue of access to medicines in Africa: Challenges and recommendations (2022)The price of innovation: new estimates of drug development costs (2003)Cochrane Handbook for Systematic Reviews of Interventions (2008)Cochrane Handbook for Systematic Reviews of Interventions (2010)Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending (2017)Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012)Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014)Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016)Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)Household catastrophic health expenditure: a multicountry analysis (2003)The World Health report 2006 1 : Working together for health 2 (2006)The commercial determinants of health (2016)Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40 (2018)Universal health coverage and primary care, Thailand (2019)Towards universal health coverage: lessons from 10 years of healthcare reform in China (2020)Capability and Well‐Being (1993)Capability and Well-Being (2007)The need for a complex systems model of evidence for public health (2017)Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda (2018)Understanding the rise of cardiometabolic diseases in low- and middle-income countries (2019)The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion (2020)The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries (2007)Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data (2015)Insulin prices, availability and affordability in 13 low-income and middle-income countries (2019)Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries (2020)Global accessibility of therapeutics for diabetes mellitus (2022)Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement (2016)Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories (2018)Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024)Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal (2024)‘Ayushman Bharat’ Program and Universal Health Coverage in India (2018)Health for Everyone? (2019)Tackling Vulnerability in the Informal Economy (2019)
this work references cited by second hop

References

  • 2018Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 20178,823 cited
  • 2017Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 20164,999 cited
  • 2010Health systems financing and the path to universal coverage1,286 cited
  • 2016Essential medicines for universal health coverage661 cited
  • 2017Tracking Universal Health Coverage: 2017 Global Monitoring Report653 cited
  • 2018Health systems development in Thailand: a solid platform for successful implementation of universal health coverage379 cited
  • 2018Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals374 cited
  • 2018Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study203 cited
  • 2013Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration202 cited
  • 2010Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World168 cited
  • 2014Chronic non-communicable diseases and the challenge of universal health coverage: insights from community-based cardiovascular disease research in urban poor communities in Accra, Ghana139 cited
  • 2014The role of law and governance reform in the global response to non-communicable diseases

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

78 cited
  • 2013Advancing universal coverage of healthcare in China: translating political will into policy and practice55 cited
  • 2018Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment54 cited
  • 2011Action on social determinants of health is essential to tackle noncommunicable diseases24 cited
  • Cited by

    No citing works inside the corpus for this window.